drugset / Trial / NCT00877929

Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus

NCT00877929

Phase 3 Completed 706 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To demonstrate that the fixed dose combination of telmisartan and amlodipine is more effective in lowering blood pressure.

Timeline

Start
2009-02
Primary completion
2010-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 10 mg
Subject Telmisartan Other / unclassified 80 mg

Indications